Bercede, Vicente Jr .
HRN: 10-74-51 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/07/2023
01/13/2023
IV
1.5g
Q8
CAP-MR, T/C PTB Relapse
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes